BeOne Medicines Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | — | Sale | 21,235 | $223.41 | $4,744,111 | 10,304 | May 13, 2025 |
| OYLER JOHN | Chief Executive Officer | Option Exercise | 4,055,415 | $0.50 | $2,027,708 | 10,154,040 | May 9, 2025 |
| Wang Xiaodong | — | Sale | 6,398 | $243.41 | $1,557,337 | 7,892 | Apr 14, 2025 |
| Wu Xiaobin | President, COO & GM China | Sale | 12,221 | $282.76 | $3,455,610 | 5,083 | Apr 1, 2025 |
| Wang Xiaodong | — | Sale | 2,694 | $259.86 | $700,063 | 29,723 | Mar 18, 2025 |
| Wu Xiaobin | President, COO & GM China | Sale | — | — | — | — | Mar 14, 2025 |
| Wang Xiaodong | — | Gift | 158,717 | — | — | 5,082,165 | Mar 11, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 1,900 | $238.74 | $453,606 | 39,310 | Mar 10, 2025 |
| OYLER JOHN | Chief Executive Officer | Option Exercise | 58,590 | $6.50 | $380,835 | 58,590 | Mar 7, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 8,200 | $258.91 | $2,123,062 | 14,811 | Mar 5, 2025 |
| Wu Xiaobin | President, COO & GM China | Sale | 200 | $263.00 | $52,600 | — | Mar 5, 2025 |
| Wang Lai | Global Head of R&D | Award / Grant | 69,251 | — | — | 990,171 | Mar 5, 2025 |
| Lee Chan Henry | SVP, General Counsel | Award / Grant | 40,209 | — | — | 246,142 | Mar 5, 2025 |
| Rosenberg Aaron | Chief Financial Officer | Award / Grant | 48,581 | — | — | 167,128 | Mar 5, 2025 |
| Wang Xiaodong | — | Sale | 2,000 | $252.72 | $505,440 | 5,446 | Mar 4, 2025 |
| OYLER JOHN | Chief Executive Officer | Option Exercise | 1,220,531 | $0.50 | $610,266 | 4,199,364 | Mar 3, 2025 |
| Wu Xiaobin | President, COO & GM China | Sale | — | — | — | — | Feb 28, 2025 |
| Baker Bros. Advisors (GP) LLC | — | Sale | 60,851 | $260.00 | $15,821,260 | 730,642 | Feb 28, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 1,205 | $275.00 | $331,375 | — | Feb 27, 2025 |
| Wang Lai | Global Head of R&D | Sale | 479 | $256.70 | $122,959 | 2,619 | Feb 21, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 100 | $260.22 | $26,022 | — | Feb 21, 2025 |
| Wu Xiaobin | President, COO & GM China | Option Exercise | 30,654 | $169.65 | $5,200,451 | 30,654 | Feb 20, 2025 |
| Wang Xiaodong | — | Sale | 9,776 | $227.00 | $2,219,152 | 1,400 | Feb 4, 2025 |
| Wang Xiaodong | — | Option Exercise | 41,760 | $6.50 | $271,440 | 41,760 | Jan 7, 2025 |
| OYLER JOHN | Chief Executive Officer | Option Exercise | 1,300,000 | $0.50 | $650,000 | 2,978,833 | Dec 14, 2024 |
| Wang Xiaodong | — | Sale | 993 | $191.78 | $190,438 | 2,399 | Dec 10, 2024 |
| Baker Brothers Life Sciences LP | — | Sale | 33,943 | $208.01 | $7,060,483 | 9,657,351 | Dec 9, 2024 |
| Wu Xiaobin | President, COO & GM China | Sale | — | — | — | — | Dec 6, 2024 |
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. | — | Sale | 17,842,500 | $200.00 | $3,568,500,000 | 125,045,741 | Dec 2, 2024 |
| Wang Xiaodong | — | Sale | 12,293 | $191.22 | $2,350,667 | 7,388 | Nov 26, 2024 |
| OYLER JOHN | Chief Executive Officer | Sale | 1,452 | $236.37 | $343,209 | — | Oct 8, 2024 |
| Sharp Shalini | — | Award / Grant | 8,151 | — | — | 8,151 | Sep 30, 2024 |
| Lee Chan Henry | SVP, General Counsel | Sale | 1,202 | $237.10 | $284,994 | — | Sep 30, 2024 |
| Wang Lai | Global Head of R&D | Sale | 5,000 | $220.35 | $1,101,750 | — | Sep 27, 2024 |
| Wu Xiaobin | President, COO & GM China | Sale | 500 | $200.00 | $100,000 | 4,500 | Sep 19, 2024 |
| Wu Xiaobin | President, COO & GM China | Sale | 700 | $191.20 | $133,840 | 274 | Sep 3, 2024 |
| Ball Titus B. | Principal Accounting Officer | Sale | 137 | $189.94 | $26,022 | — | Sep 3, 2024 |
| Wang Xiaodong | — | Gift | 301,457 | — | — | 5,266,973 | Aug 12, 2024 |
| Rosenberg Aaron | Chief Financial Officer | Award / Grant | 118,547 | — | — | 118,547 | Aug 9, 2024 |
| Lee Chan Henry | SVP, General Counsel | Sale | 834 | $160.57 | $133,915 | — | Jul 30, 2024 |
| Wang Julia Aijun | Chief Financial Officer | Sale | 472 | $143.90 | $67,921 | — | Jul 1, 2024 |
| Wang Julia Aijun | Chief Financial Officer | Sale | 899 | $155.66 | $139,938 | — | Jun 24, 2024 |
| Wang Lai | Global Head of R&D | Sale | 2 | $161.10 | $322 | — | Jun 24, 2024 |
| Wu Xiaobin | President, COO & GM China | Sale | 23 | $161.27 | $3,709 | — | Jun 24, 2024 |
| OYLER JOHN | Chief Executive Officer | Sale | 400 | $160.12 | $64,048 | — | Jun 24, 2024 |
| Wu Xiaobin | President, COO & GM China | Sale | 300 | $155.15 | $46,545 | 300 | Jun 18, 2024 |
| OYLER JOHN | Chief Executive Officer | Sale | 608 | $159.40 | $96,915 | 376 | Jun 17, 2024 |
| Wang Julia Aijun | Chief Financial Officer | Sale | 154 | $158.24 | $24,369 | 762 | Jun 17, 2024 |
| Wang Lai | Global Head of R&D | Sale | 478 | $159.00 | $76,002 | 1,626 | Jun 17, 2024 |
| Lee Chan Henry | SVP, General Counsel | Sale | 208 | $159.68 | $33,213 | 129 | Jun 17, 2024 |